Biofrontera Inc. (BFRIW) stock
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Biofrontera enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Biofrontera's enterprise value was $6.79M on Oct 19, 2026, against $3.91M a year earlier. Over the last 5 years it ranged from -$11.95M to $58.44M, with a median of $4.20M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $6.79M | +110.6% |
| 2025 | Dec 31, 2025 | $3.22M | -24.1% |
| 2024 | Dec 31, 2024 | $4.24M | +1058.6% |
| 2023 | Dec 29, 2023 | $366.33K | – |
| 2022 | Dec 30, 2022 | -$5.93M | -110.1% |
| 2021 | Dec 31, 2021 | $58.44M | – |